In part of the AML cases (1/19 in our CD34-positive AML population, AML-808), the CD34+CD38– compartment can not be segregated into HSC and LSC by expression of aberrant immunophenotypic markers or by scatter properties. The gene discussed is CD34; the disease is acute myeloid leukemia.